From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice
Arun Kedia, Managing Director, VAV Life Sciences, elaborates how NDDS have proved to be beneficial with applications across…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Mucormycosis
Cadila Pharma launches Posaconazole to treat fungal diseases
National Task Force on COVID-19 has recommended Posaconazole, for the treatment of Mucormycosis
Govt is taking steps to boost availability of Amphotericin B, allots 6.67 lakh vials to states, UTs
The existing manufacturers have also been called upon to increase the production of Liposomal Amphotericin-B, informed Chemicals…
Mankind Pharma launches Posaconazole tablets to treat black fungus
The tablets have been launched under the brand name POSAFORCE 100
Preparing for the third wave
Even if we need global help to meet today's needs, we have to shore up infrastructure for future disruptions
IIT Hyderabad is ready for tech transfer of oral drug to treat ‘black fungus’
A 60-mg tablet, which can be priced at about Rs 200, is patient friendly as its slow and sustained release in the body reduces…
Strides, TLC collaborate to launch black fungus drug in India
The CDSCO has approved TLC's new drug application (NDA) of Amphotericin B Liposome for Injection 50 mg in India for immediate…
Government working to eliminate shortage of Amphotericin-B drug: Mansukh Mandaviya
He said that existing pharma companies have already started ramping up the production of the drug which is key for treating…
Bharat Biotech’s Karnataka facility will be able to make 4-5 cr Covaxin doses a month by Aug…
He also said that Bharat Biotech's facility in Hyderabad can produce one crore doses of COVID vaccine a month
Govt in talks with manufacturers to ramp up availability of Amphotericin B to treat Mucormycosis
States have been requested to put in place a mechanism for equitable distribution of supplies amongst government and private…